Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
Optimize radiological workflows with automated diagnostics | Daniel Drieling | MeVis Medical Solutions AG | NLST | Mar 29, 2019 | NLST-491 |
Optimizing Early Lung Cancer Detection Utilizing Computer Vision Techniques | Stephen Lam | British Columbia Cancer Agency | NLST | Jun 18, 2014 | NLST-78 |
Optimizing Lung Cancer Early Detection by LDCT via Computer Vision | Kingshuk Das | AnimanDx Inc | NLST | Nov 14, 2019 | NLST-602 |
Optimizing Lung Cancer Screening Nodule Evaluation | Mark Hammer | Brigham and Women's Hospital | NLST | Sep 24, 2021 | NLST-838 |
Optimizing lung cancer treatments from public clinical trial data | Shimon Sheiba | Causalis.ai | NLST | Apr 22, 2021 | NLST-729 |
Optimizing prostate cancer PSA screening through genetic profiling: Towards a personalized screening approach | Laurent Briollais | Lunenfeld-Tanenbaum Research Institute - Mount Sinai Hospital | PLCO | Mar 1, 2016 | PLCO-194 |
Optimizing radiological workflow with automated diagnostics | Mark-Jan Harte | Aidence | NLST | Nov 25, 2015 | NLST-181 |
Optimizing the Implementation of Novel Diagnostic Tests for Prostate, Lung, and Colon Cancer | Grant Langseth | OncoCellMDx | PLCO | Dec 29, 2015 | PLCO-185 |
Oral microbiome and risk of pancreatic cancer | Jiyoung Ahn | New York University | PLCO | Apr 27, 2012 | 2011-0271 |
Oral microbiome in esophageal adenocarcinoma | ZHIHENG PEI | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | PLCO | 2014-0262 | |
ORIENT: tOwaRds Informed dEcisions iN colorecTal cancer screening. | Guido Van Hal | The University of Antwerp | PLCO | Mar 7, 2022 | PLCO-937 |
Other cancer incidence in PLCO | Ellen Chang | GRAIL, LLC | PLCO | Feb 8, 2023 | PLCO-1157 |
Other Cancers - NHL and Tobacco/ Alcohol | Lindsay Morton | NCI, DCEG, REB | PLCO | Jul 1, 2006 | 2006-0124 |
Other Cancers - Pancreas and NSAIDs | Rachael Stolzenberg-Solomon | NCI, DCEG, NEB | PLCO | Jul 1, 2006 | 2006-0239 |
Outcomes among patients with self-reported occupational exposures in the NLST | Christopher Donatelli | University Hospitals Cleveland Medical Center | NLST | Oct 13, 2016 | NLST-250 |
Outcomes associated with significant incidental findings in lung cancer screening | Ilana Gareen | Brown University | NLST | May 10, 2017 | NLST-308 |
Outcomes of Lung Cancer CT Screening in Clinical Practice Compared to the National Lung Screening Trial | David Gierada | Washington University | NLST | Jul 12, 2018 | NLST-426 |
Outcomes of stage I non-small cell lung cancer patients treated with surgery versus radiation therapy within the NLST | Omar Abdel-Rahman | Avicenna Oncology center | NLST | Oct 11, 2018 | NLST-445 |
Outdoor air pollution exposures and incident cancer risk in the PLCO cohort | Rena Jones | National Cancer Institute | PLCO | Mar 22, 2022 | PLCO-947 |
Out of pocket costs associated with Lung Cancer Screening | Daniel Reuland | University of North Carolina at Chapel Hill Comprehensive Cancer Center | NLST | Apr 2, 2019 | NLST-492 |